Linu M. John

Malov, 2760, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia.

Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia.

Journal: Cell metabolism

Published: March 25, 2026

Correction to "NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin".

Correction to "NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin".

Journal: Journal of medicinal chemistry

Published: December 12, 2024

NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin.

NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin.

Journal: Journal of medicinal chemistry

Published: July 03, 2024

Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia.

Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia.

Journal: Cell metabolism

Published: June 11, 2024

Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans.

Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans.

Journal: Cell reports

Published: February 16, 2024

Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1/3 KO than in WT mice.

Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1/3 KO than in WT mice.

Journal: European journal of pharmacology

Published: January 26, 2023

NPFF Decreases Activity of Human Arcuate NPY Neurons: A Study in Embryonic-Stem-Cell-Derived Model.

NPFF Decreases Activity of Human Arcuate NPY Neurons: A Study in Embryonic-Stem-Cell-Derived Model.

Journal: International journal of molecular sciences

Published: February 15, 2022

Housing-temperature reveals energy intake counter-balances energy expenditure in normal-weight, but not diet-induced obese, male mice.

Housing-temperature reveals energy intake counter-balances energy expenditure in normal-weight, but not diet-induced obese, male mice.

Journal: Communications biology

Published: February 11, 2022

Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss.

Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss.

Journal: Obesity (Silver Spring, Md.)

Published: September 10, 2021

A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice.

A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice.

Journal: The European journal of neuroscience

Published: April 26, 2021

In vitro prediction of in vivo pseudo-allergenic response via MRGPRX2.

In vitro prediction of in vivo pseudo-allergenic response via MRGPRX2.

Journal: Journal of immunotoxicology

Published: February 11, 2021

FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation.

FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation.

Journal: Endocrine connections

Published: July 02, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026